Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational Results available

PK and Safety of Remdesivir for Treatment of COVID-19 in Pregnant and Non-Pregnant Women in the US

ClinicalTrials.gov ID: NCT04582266

Public ClinicalTrials.gov record NCT04582266. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 9:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Pharmacokinetics and Safety of Remdesivir for Treatment of COVID-19 in Pregnant and Non-Pregnant Women in the United States

Study identification

NCT ID
NCT04582266
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Enrollment
54 participants

Conditions and interventions

Conditions

Interventions

  • Remdesivir Drug

Drug

Eligibility (public fields only)

Age range
Not listed
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 30, 2021
Primary completion
Apr 12, 2022
Completion
Apr 12, 2022
Last update posted
Jun 8, 2023

2021 – 2022

United States locations

U.S. sites
10
U.S. states
8
U.S. cities
9
Facility City State ZIP Site status
David Geffen School of Medicine at UCLA (Site #: 5112) Los Angeles California 90095
Childrens Hospital (U. Colorado, Denver) NICHD CRS (Site #: 5052) Denver Colorado 80218-1088
Pediatric Perinatal HIV Clinical Trials Unit (Site #: 5127) Miami Florida 33136
Emory University School of Medicine (Site #: 5030) Atlanta Georgia 30308
Rush University Cook County Hospital NICHD CRS (Site #: 5083) Chicago Illinois 60612
Lurie Children's Hospital of Chicago (LCH) CRS (Site #: 4001) Chicago Illinois 60614
Johns Hopkins University NICHD CRS (Site #: 5092) Baltimore Maryland 21287
Stony Brook University Medical Center (Site #: 5040) Stony Brook New York 11794
Bronx-Lebanon Hospital Center (Site #: 5114) The Bronx New York 10457
Texas Children's Hospital (Site #: 5128) Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04582266, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 8, 2023 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04582266 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →